FFC#17/2015

Phage Therapy against Pseudomonas aeruginosa infections in Cystic Fibrosis patients

AREA 3 Bronchopulmonary infection

FFC#17/2015

Phage Therapy against Pseudomonas aeruginosa infections in Cystic Fibrosis patients
€ 0 still needed
0%
€ 12.000 goal

pRINCIPAL INVESTIGATOR

Daniela Erica Ghisotti (Dipartimento di Bioscienze – Università degli Studi di Milano)

Researchers

3

Category

AREA 3 Bronchopulmonary infection

Duration

1 year

Goal

€ 12.000

Funds raised

€ 12.000

Objectives

The therapy based on phages, virus which are natural enemies of the bacteria, is garnering renewed interest as bacterial resistance to antibiotics is becoming increasingly widespread. Advantages on antibiotic therapy are that bacteriophages: 1) multiply at the infection site, increasing their number, whereas antibiotics are metabolized and eliminated from the body; 2) target only specific bacteria, with no effect on commensal flora; 3) can overcome bacterial resistance; 4) have the capacity to reach bacteria trapped inside biofilms. Aim of this project was the characterization of several phages used currently in Eastern Europe, testing their ability to infect Italian P. aeruginosa clinical strains, and to isolate novel phages from Italian samples. Moreover, the ability of the phages to dissolve the biofilms formed by P. aeruginosa clinical strains was evaluated.

WHO ADOPTED THE PROJECT

Delegazione FFC di Taranto e Gruppi di Sostegno FFC di Massafra e Alberobello

€ 12.000

Delegazione FFC di Manciano Grosseto e Famiglia Catalano

€ 12.000

Hotel Metropole

€ 10.000

OTHER PROJECTS

Discover the other projects

GMSG#1/2025

Developing PNAs to Block Essential Bacterial Genes and Create New Antimicrobial Therapies

FFC#1/2025

Understanding the process of epithelial-mesenchymal transition to preserve tissue function and reduce long-term complications (e.g. cancer)

FFC#2/2025

Developing RNA-targeted therapies to regulate gene expression and restore CFTR synthesis